DBV Technologies S.A. (DBVT) stock
Close on Nov 10, 2026Market cap $723.72MP/E –Yield –
DBV Technologies S.A. saw revenue fall 31.6% to $3.84M over the twelve months to Sep 30, 2026. Free cash flow was -$191.71M. At the latest close the market valued the company at $723.72M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $723.72M
- P/E ratio
- –
- Price to sales
- 188.67
- Price to book
- 4.87
- Dividend yield
- –
- Free cash flow yield
- -26.49%
Fundamentals
- Revenue
- $3.84M
- Net income
- -$207.35M
- EPS, diluted
- -$0.61
- Free cash flow
- -$191.71M
- Book value per share
- $0.33
- Diluted shares
- 451M
Trading
- Next earnings
- Mar 25, 2027 (estimated, during market hours)
- Previous close
- $11.05
- Open
- $10.95
- Day's range
- $10.95 – $11.57
- Volume
- 162,616
- Average volume (20 days)
- 414,337
- Beta (5 years)
- 0.58
- 52-week range
- $8.63 – $26.18
- RSI (14 days)
- 61.5
- Volatility (1 year)
- 71.7%
- Relative volume
- 0.46×
- WACC
- 7.8%
Market cap history
Month-end market cap since 2016, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 10, 2026. The S&P 500 is measured by the SPY fund.
| Period | DBVT | S&P 500 | Difference | DBVT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +17.4% | -3.7% | +21.1 pts | ||
| 3 months | -19.3% | -2.7% | −16.6 pts | ||
| Year to date | -40.0% | +10.8% | −50.8 pts | ||
| 1 year | -15.2% | +11.2% | −26.5 pts | ||
| 3 years | +505.8% | +76.5% | +429.3 pts | +82.3% | +20.8% |
| 5 years | +83.9% | +72.9% | +10.9 pts | +13.0% | +11.6% |
| 10 years | -84.4% | +304.8% | −389.2 pts | -16.9% | +15.0% |
Eleven years at a glance
Fiscal years 2015 to 2025 and trailing twelve months, USD
Revenue
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases DBV Technologies filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- Results
- News
- Results
- Results
About DBV Technologies
Biological Products, (No Diagnostic Substances)
DBV Technologies is a clinical-stage biopharmaceutical company that develops epicutaneous immunotherapy treatments using a skin patch platform called Viaskin. The technology delivers microgram amounts of antigens through intact skin to activate immune cells without entering the bloodstream. The company's primary candidate is the Viaskin Peanut patch, which is evaluated for treating peanut allergies in toddlers and children. Additionally, the firm develops earlier-stage product candidates, including Viaskin Milk for cow's milk allergy and eosinophilic esophagitis. Its intended end users are pediatric patients suffering from severe food allergies, supported by parents, caregivers, allergists, and pediatricians.
Company profile, executives and historyDBV Technologies stock: common questions
What is DBV Technologies's stock price?
DBVT closed at $11.51 on Nov 10, 2026, up 4.16% on the day. Over the past 52 weeks it traded between $8.63 and $26.18.
What is DBV Technologies's market cap?
DBV Technologies was worth $723.72M at the close on Nov 10, 2026: the share price times the diluted shares outstanding.
What is DBVT's P/E ratio?
DBV Technologies lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.61), so it has no meaningful P/E ratio.
How much revenue does DBV Technologies make?
DBV Technologies reported revenue of $3.84M for the twelve months to Sep 30, 2026, down 31.6% from a year earlier.
Does DBV Technologies pay a dividend?
No. DBV Technologies has not paid a cash dividend over the last twelve months.
When does DBV Technologies report earnings next?
DBV Technologies is expected to report Q4 FY2026 results on Mar 25, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has DBVT stock performed over the past year?
Including dividends, DBVT returned -15.2% over the past year, against +11.2% for the S&P 500.
Who are DBV Technologies's competitors?
Companies most similar to DBV Technologies by business, industry and size include ATRA, FATE, TCRX, MOLN, ELOX.
See a number that looks wrong?